The Safety and Efficacy of Direct SLT in Pseudoexfoliation Glaucoma

ClinicalTrials.gov ID: NCT07401290

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07401290. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 4:58 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Prospective, multi-center, single arm, interventional study evaluating DSLT in patients with pseudoexfoliative glaucoma.

Study identification

NCT ID: NCT07401290
Recruitment status: Not yet recruiting
Study type: Interventional
Phase: Not applicable
Lead sponsor: Vance Thompson Vision; Other
Enrollment: 40 participants

Conditions and interventions

Conditions

Pseudoexfoliation Glaucoma

Interventions

Direct selective laser trabeculoplasty Device

Device

Eligibility (public fields only)

Age range: Not listed
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 2026 (Estimated)
Primary completion: Mar 2028 (Estimated)
Completion: Mar 2028 (Estimated)
Last update posted: Feb 10, 2026

2026 – 2028

United States locations

U.S. sites: 3
U.S. states: 3
U.S. cities: 3

Facility	City	State	ZIP	Site status
Vance Thompson Vision	Alexandria	Minnesota	56308	—
Vance Thompson Vision	Omaha	Nebraska	68137	—
Vance Thompson Vision	Fargo	North Dakota	58078	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07401290, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 10, 2026 · Synced Nov 12, 2026